Contents

Current Molecular Pharmacology, Volume 5 - Number 3

GRK2 and Beta-Arrestins in Cardiovascular Disease: Established and Emerging Possibilities for Therapeutic Targeting

, 5(3): 317 - 326

Alicia N. Harvey, Kristy Nguyen and Anastasios Lymperopoulos


DOI: 10.2174/1874467211205030001




Crosstalk Signalling Role in Modulation of Drugs Side Effects

, 5(3): 327 - 339

Susanna P. Garamszegi and Nandor Garamszegi


DOI: 10.2174/1874467211205030002




Parkinson's Disease: A Role for the Immune System

, 5(3): 340 - 349

Dwight C. German, Todd Eagar and Patricia K. Sonsalla


DOI: 10.2174/1874467211205030003




G-Protein Coupled Receptor Resensitization - Appreciating the Balancing Act of Receptor Function

, 5(3): 350 - 361

Maradumane L. Mohan, Neelakantan T. Vasudevan, Manveen K. Gupta, Elizabeth E. Martelli and Sathyamangla V. Naga Prasad


DOI: 10.2174/1874467211205030004




microRNA, Cancer and Cancer Chemoprevention

, 5(3): 362 - 371

Xun Che and Chuanshu Huang


DOI: 10.2174/1874467211205030005




Molecular Mechanisms Mediating Nociceptin/Orphanin FQ Receptor Signaling, Desensitization and Internalization

, 5(3): 372 - 381

Monica Baiula, Andrea Bedini and Gioia Carbonari


DOI: 10.2174/1874467211205030006




Bevacizumab and Angiogenesis Inhibitors in the Treatment of CNS Metastases: The Road less Travelled

, 5(3): 382 - 391

Irina Veytsman, Jeanny B. Aragon-Ching and Sandra M. Swain


DOI: 10.2174/1874467211205030007




Estrogen Receptor Expression and its Relevant Signaling Pathway in Prostate Cancer: A Target of Therapy

, 5(3): 392 - 400

Yasuhiro Nakamura, Keely M McNamara and Hironobu Sasano


DOI: 10.2174/1874467211205030008




Acknowledgement To Reviewers

, 5(3): 401


DOI: 10.2174/1874467211205030009




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science